GenoFocus Inc (187420) - Total Liabilities

Latest as of March 2026: ₩82.66 Billion KRW ≈ $56.02 Million USD

Based on the latest financial reports, GenoFocus Inc (187420) has total liabilities worth ₩82.66 Billion KRW (≈ $56.02 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 187420 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

GenoFocus Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how GenoFocus Inc's total liabilities have evolved over time, based on quarterly financial data. See 187420 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

GenoFocus Inc Competitors by Total Liabilities

The table below lists competitors of GenoFocus Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Tons Lightology TWO:4972	Taiwan	NT$378.63 Million
Energía Innovación y Desarrollo Fotovoltaico S.A. MC:EIDF	Spain	€104.09 Million
Davolink Inc. KQ:340360	Korea	₩25.53 Billion
Eastern Commercial Leasing Public Company Limited BK:ECL	Thailand	฿3.14 Billion
TOUAX PA:ALTOU	USA	€432.09 Million
ENERGIA IN.Y DES. EO 025 F:F63	Germany	€119.79 Million
Hitek Global Inc. Ordinary Share NASDAQ:HKIT	USA	$7.67 Million
Multi Hanna Kreasindo Tbk Pt JK:MHKI	Indonesia	Rp30.62 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down GenoFocus Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 187420 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.82	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.61	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GenoFocus Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GenoFocus Inc (2014–2025)

The table below shows the annual total liabilities of GenoFocus Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩81.08 Billion ≈ $54.95 Million	-33.81%
2024-12-31	₩122.49 Billion ≈ $83.01 Million	+71.31%
2023-12-31	₩71.50 Billion ≈ $48.46 Million	-35.01%
2022-12-31	₩110.02 Billion ≈ $74.56 Million	+32.17%
2021-12-31	₩83.24 Billion ≈ $56.41 Million	+13.32%
2020-12-31	₩73.46 Billion ≈ $49.78 Million	+92.90%
2019-12-31	₩38.08 Billion ≈ $25.81 Million	+276.16%
2018-12-31	₩10.12 Billion ≈ $6.86 Million	+70.65%
2017-12-31	₩5.93 Billion ≈ $4.02 Million	+735.70%
2016-12-31	₩709.87 Million ≈ $481.07K	-3.57%
2015-12-31	₩736.18 Million ≈ $498.90K	-89.89%
2014-12-31	₩7.28 Billion ≈ $4.93 Million	--

About GenoFocus Inc

KQ:187420 Korea Specialty Chemicals

Market Cap

$29.03 Million

₩42.83 Billion KRW

Market Cap Rank

#23832 Global

#1625 in Korea

Share Price

₩1470.00

Change (1 day)

+2.15%

52-Week Range

₩1373.00 - ₩3365.00

All Time High

₩17350.00